Fagron NV

Brussels Stock Exchange FAGR.BR

Fagron NV Market Capitalization on January 14, 2025: USD 1.27 B

Fagron NV Market Capitalization is USD 1.27 B on January 14, 2025, a -6.99% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Fagron NV 52-week high Market Capitalization is USD 1.57 B on August 02, 2024, which is 23.58% above the current Market Capitalization.
  • Fagron NV 52-week low Market Capitalization is USD 1.24 B on January 06, 2025, which is -2.29% below the current Market Capitalization.
  • Fagron NV average Market Capitalization for the last 52 weeks is USD 1.44 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
Brussels Stock Exchange: FAGR.BR

Fagron NV

CEO Mr. Rafael Padilla
IPO Date Oct. 5, 2007
Location Belgium
Headquarters Venecoweg 20A
Employees 3,647
Sector Health Care
Industries
Description

Fagron NV, a pharmaceutical compounding company, provides personalized medicine care to hospitals, pharmacies, clinics, and patients. The company also innovates concepts, vehicles, and formulations for pharmaceutical compounding. In addition, it supplies raw materials, utensils and equipment, semi-finished products, vehicles, and sterile and non-sterile compounded medicines. Further, the company offers education and training program to prescribers and pharmacists through the Fagron Academy. It has operations in Latin America, North America, Europe, the Middle East, and Africa. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Similar companies

BEKB.BR

NV Bekaert SA

USD 33.74

-0.13%

ARGX.BR

argenx SE

USD 673.61

1.66%

ONTEX.BR

Ontex Group NV

USD 8.29

0.48%

TESB.BR

Tessenderlo Group NV

USD 19.81

0.71%

StockViz Staff

January 15, 2025

Any question? Send us an email